Clear All
12482 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
75907-0058-60 75907-0058 Tamoxifen Citrate Tamoxifen Citrate 10.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Aug 22, 2024 In Use
60505-3035-06 60505-3035 Tamoxifen Citrate Tamoxifen Citrate Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Nov 30, 2012 Dec 1, 2012 No Longer Used
60505-3035-03 60505-3035 Tamoxifen Citrate Tamoxifen Citrate Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Nov 30, 2012 Dec 1, 2012 No Longer Used
13632-0123-01 13632-0123 Tamoxifen Citrate Soltamox 10.0 mg/5mL Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Oct 1, 2012 Aug 1, 2018 In Use
60505-3035-05 60505-3035 Tamoxifen Citrate Tamoxifen Citrate Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Nov 30, 2012 Dec 1, 2012 No Longer Used
63629-4413-02 63629-4413 Tamoxifen Citrate Tamoxifen Citrate 20.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Mar 7, 2011 In Use
00093-0782-56 00093-0782 Tamoxifen Citrate Tamoxifen Citrate 20.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Feb 21, 2003 May 31, 2018 No Longer Used
00591-2233-30 00591-2233 Tamoxifen Citrate Tamoxifen Citrate Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Mar 7, 2011 May 31, 2014 No Longer Used
71335-1424-05 71335-1424 Tamoxifen Citrate Tamoxifen Citrate 20.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Dec 28, 2021 In Use
70771-1185-06 70771-1185 Tamoxifen Citrate Tamoxifen Citrate 20.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Jan 3, 2018 In Use
68382-0826-28 68382-0826 Tamoxifen Citrate Tamoxifen Citrate 10.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Jan 3, 2018 In Use
51862-0447-60 51862-0447 Tamoxifen Citrate Tamoxifen Citrate 10.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Aug 3, 2016 Jul 31, 2022 In Use
51862-0682-00 51862-0682 TAMOXIFEN CITRATE SOLTAMOX 20.0 mg/10mL Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Dec 6, 2021 In Use
70771-1184-03 70771-1184 Tamoxifen Citrate Tamoxifen Citrate 10.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Jan 3, 2018 Dec 5, 2019 In Use
51862-0446-30 51862-0446 Tamoxifen Citrate Tamoxifen Citrate 20.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Aug 3, 2016 In Use
68382-0826-16 68382-0826 Tamoxifen Citrate Tamoxifen Citrate 10.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Jan 3, 2018 In Use
75907-0058-10 75907-0058 Tamoxifen Citrate Tamoxifen Citrate 10.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Aug 22, 2024 In Use
63629-4413-05 63629-4413 Tamoxifen Citrate Tamoxifen Citrate 20.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Mar 7, 2011 In Use
57894-0469-01 57894-0469 Talquetamab TALVEY 3.0 mg/1.5mL Immunotherapy T Cell Receptor (TCR) GPRC5D, CD3 Subcutaneous Aug 9, 2023 In Use
57894-0470-01 57894-0470 Talquetamab TALVEY 40.0 mg/mL Immunotherapy T Cell Receptor (TCR) GPRC5D, CD3 Subcutaneous Aug 9, 2023 In Use
55513-0079-01 55513-0079 Talimogene Laherparepvec Imlygic 100000000.0 [PFU]/mL Immunotherapy Therapeutic Cancer Vaccine Oncolytic Virus Intralesional Nov 2, 2015 In Use
55513-0078-01 55513-0078 Talimogene Laherparepvec Imlygic 1000000.0 [PFU]/mL Immunotherapy Therapeutic Cancer Vaccine Oncolytic Virus Intralesional Nov 2, 2015 In Use
84651-0200-93 84651-0200 Taletrectinib IBTROZI 272.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor ROS1, TRKA, TRKB, TRKC Oral Jun 13, 2025 In Use
63539-0031-30 63539-0031 Talazoparib Talzenna 1.0 mg/1 Chemotherapy Enzyme Inhibitor PARP Oral Jul 9, 2024 In Use
00069-1235-30 00069-1235 Talazoparib Talzenna 0.35 mg/1 Chemotherapy Enzyme Inhibitor PARP Oral Jun 21, 2023 Oct 31, 2025 No Longer Used

Found 12482 results — Export these results